Literature DB >> 33529442

The role of miR-29 family in disease.

Masahiro Horita1, Colin Farquharson1, Louise A Stephen1.   

Abstract

MicroRNAs are small noncoding RNAs that can bind to the target sites in the 3'-untranslated region of messenger RNA to regulate posttranscriptional gene expression. Increasing evidence has identified the miR-29 family, consisting of miR-29a, miR-29b-1, miR-29b-2, and miR-29c, as key regulators of a number of biological processes. Moreover, their abnormal expression contributes to the etiology of numerous diseases. In the current review, we aimed to summarize the differential expression patterns and functional roles of the miR-29 family in the etiology of diseases including osteoarthritis, osteoporosis, cardiorenal, and immune disease. Furthermore, we highlight the therapeutic potential of targeting members of miR-29 family in these diseases. We present miR-29s as promoters of osteoblast differentiation and apoptosis but suppressors of chondrogenic and osteoclast differentiation, fibrosis, and T cell differentiation, with clear avenues for therapeutic manipulation. Further research will be crucial to identify the precise mechanism of miR-29 family in these diseases and their full potential in therapeutics.
© 2021 The Authors. Journal of Cellular Biochemistry Published by Wiley Periodicals LLC.

Entities:  

Keywords:  cardiorenal disease; immune disease; miRNA-29; microRNA; osteoarthritis; osteoporosis

Year:  2021        PMID: 33529442     DOI: 10.1002/jcb.29896

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2021-10-21       Impact factor: 2.980

Review 2.  MicroRNA-Based Diagnosis and Therapy.

Authors:  Phuong T B Ho; Ian M Clark; Linh T T Le
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

3.  MiR-29a-3p Improves Acute Lung Injury by Reducing Alveolar Epithelial Cell PANoptosis.

Authors:  Yanhui Cui; Xueqin Wang; Fengyu Lin; Wen Li; Yuhao Zhao; Fei Zhu; Hang Yang; Mingjun Rao; Yi Li; Huaying Liang; Minhui Dai; Ben Liu; Lingli Chen; Duoduo Han; Rongli Lu; Wenzhong Peng; Yan Zhang; Chao Song; Yanwei Luo; Pinhua Pan
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

Review 4.  MicroRNA regulation of B cell receptor signaling.

Authors:  Timothy C Borbet; Marcus J Hines; Sergei B Koralov
Journal:  Immunol Rev       Date:  2021-09-14       Impact factor: 12.988

5.  miR-29cb2 promotes angiogenesis and osteogenesis by inhibiting HIF-3α in bone.

Authors:  Liping Ouyang; Yingxiao Sun; Dan Lv; Xiaochun Peng; Xiaoming Liu; Lei Ci; Guoning Zhang; Bo Yuan; Ling Li; Jian Fei; Jun Ma; Xuanyong Liu; Yun Liao
Journal:  iScience       Date:  2021-12-10

6.  miR-29b inhibits TGF-β1-induced cell proliferation in articular chondrocytes.

Authors:  Masahiro Horita; Shun-Neng Hsu; Anna Raper; Colin Farquharson; Louise A Stephen
Journal:  Biochem Biophys Rep       Date:  2022-01-24

7.  MiRNA-29b and miRNA-497 Modulate the Expression of Carboxypeptidase X Member 2, a Candidate Gene Associated with Left Ventricular Hypertrophy.

Authors:  Jana Subrova; Karen Böhme; Allan Gillespie; Miriam Orphal; Claudia Plum; Reinhold Kreutz; Andreas Eisenreich
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

Review 8.  Role of microRNAs in type 2 diseases and allergen-specific immunotherapy.

Authors:  Constanze A Jakwerth; Hannah Kitzberger; Dimitrii Pogorelov; Annika Müller; Simon Blank; Carsten B Schmidt-Weber; Ulrich M Zissler
Journal:  Front Allergy       Date:  2022-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.